Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...

For decades, scientists assumed that order drives efficiency. Yet in the bustling machinery of mitochondria — the organelles that crank out adenosine ...

Remember seeing your triglyceride levels in your lab report? Ah! Fats you may dismiss, thinking of the next gym work you need to head to. Fatty acids are broken down via a process called β-oxidation.

A new discovery by researchers from Adelaide University, in collaboration with Denmark's Carlsberg Research Laboratory, will ...

Research from NeuroQure, a biotechnology company specializing in autism spectrum disorder, has led to the development of a ...

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 1 ...

N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a drug discovery company that is also investing in solar energy ...

In a study published in Nature on January 28, a research team led by Eric H. Xu (Xu Huaqiang) from the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences, along with Ma Xiong from ...

When people talk about “burning fat,” it sounds like something melts away inside your body and vanishes. What actually ...

In a study published in Nature on January 28, a research team led by Eric H. Xu (XU Huaqiang) from the Shanghai Institute of Materia Medica of the ...

Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease, affecting more than ...